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In Brief
Neutrophils release chromatin in the form
of neutrophil extracellular traps (NETs).
Amulic et al. show that NET formation
involves activation of cell-cycle markers
and identify CDK4/6 as regulators of the
process. Cdk6 knockout mice, which are
impaired in NET formation, are more
susceptible to Candida albicans
infection.
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Neutrophils are essential for immune defense and
can respond to infection by releasing chromatin in
the form of neutrophil extracellular traps (NETs).
Here we show that NETs are induced by mitogens
and accompanied by induction of cell-cycle markers,
including phosphorylation of the retinoblastoma
protein and lamins, nuclear envelope breakdown,
and duplication of centrosomes. We identify cyclin-
dependent kinases 4 and 6 (CDK4/6) as essential reg-
ulators of NETs and show that the response is
inhibited by the cell-cycle inhibitor p21Cip. CDK6, in
neutrophils, is required for clearance of the fungal
pathogen Candida albicans. Our data describe a
function for CDK4/6 in immunity.
INTRODUCTION
Neutrophils are the most abundant immune cells in the blood-
stream. They are essential for survival; in humans a lack of neu-
trophils results in severe immunodeficiency and a drastically
reduced lifespan, as for example in individuals with mutations
causing congenital neutropenias (Klein, 2011). Neutrophils are
produced in the bone marrow from dividing progenitors. After
maturing and exiting the cell cycle they move to the circulatory
system where they are thought to have a short lifespan. Upon
infection or injury they migrate into affected tissues where they
directly kill pathogens, as well as shaping the ensuing adaptive
immune response (Amulic et al., 2012; Mantovani et al., 2011).
Neutrophils kill microbes by phagocytosis, production of reac-
tive oxygen species (ROS), and by release of various microbici-
dal proteins. Before activation, these antimicrobials are kept in
intracellular storage vesicles called granules. When the cell
senses pathogens, the antimicrobials can be released by a
process called degranulation, whereby the granules fuse with
the plasma membrane and release their contents. An additionalDevelopmenantimicrobial strategy has been described, which entraps path-
ogens in neutrophil extracellular traps (NETs) (Brinkmann et al.,
2004). These consist of extruded chromatin bound to various
antimicrobials from the granules. By associating with NETs, the
antimicrobial molecules are physically limited from diffusing
away from their site of action, which may enhance their killing
capacity, as well as limit collateral damage to host tissues.
NETs are triggered by large pathogens, such as hyphal forms
ofCandida albicans (Branzk et al., 2014). Furthermore, excessive
NET release is associated with a growing list of inflammatory and
autoimmune diseases, including systemic lupus erythematosus
(SLE) (Kaplan and Radic, 2012), atherosclerosis (Warnatsch
et al., 2015), diabetes (Wong et al., 2015), vasculitis (Kaplan
and Radic, 2012), thrombosis (Martinod and Wagner, 2014),
sepsis (Camicia et al., 2014), and cancer (Park et al., 2016). Un-
derstanding the molecular mechanism of NET formation is thus
crucial for developing therapeutics in the context of immune de-
fense and inflammatory diseases.
NETosis is a type of neutrophil cell death, distinct from
apoptosis or necrosis, which remains poorly characterized. It is
an active process characterized by internal breakdown of nu-
clear and granular membranes, the mixing of the contents of
these compartments in the cytosol and finally, their extracellular
release via plasma membrane rupture (Fuchs et al., 2007).
Although alternative pathways have been reported (Park et al.,
2016; Parker et al., 2012; Kenny et al., 2017), the most studied
NETosis program is the one in response to C. albicans and the
mitogen phorbol myristate acetate (PMA). It requires signaling
through mitogen-activated protein kinases (MAPKs) (Hakkim
et al., 2011) and the production of ROS by the enzyme NADPH
oxidase (NOX2) (Fuchs et al., 2007). ROS are required for the
permeabilization of granules by a protein complex called the
azurosome, which allows translocation of a protease, neutrophil
elastase, into the nucleus where it cleaves histones and leads to
chromatin decondensation (Papayannopoulos et al., 2010; Met-
zler et al., 2014). Other mechanistic aspects remain unknown,
although some forms of NET formation are associatedwith citrul-
lination of histones, catalyzed by the enzyme protein arginine
deiminase 4 (PAD4) (Li et al., 2010; Kenny et al., 2017).tal Cell 43, 449–462, November 20, 2017 ª 2017 Elsevier Inc. 449
One of the most distinctive features of NETosis is the break-
down of the nuclear envelope. This characteristic sets it apart
from apoptosis, and is highly reminiscent of nuclear envelope
disintegration during mitosis in dividing cells. This observation
led us to postulate that NET induction is linked to mitogenic
reactivation of cell-cycle regulators. We show that neutrophils,
which are terminally differentiated cells, upregulate Ki-67, phos-
phorylate retinoblastoma protein (pRb), and nuclear lamins, and
separate centrosomes without replicating DNA or undergoing
cytokinesis. We demonstrate that core members of the cell-cy-
cle machinery, cyclin-dependent kinases 4 and 6 (CDK4/6), are
required for NET formation. Taken together, the data presented
here show that, in neutrophils, cell-cycle pathways are repur-
posed for controlling NETosis.
RESULTS
Mitogens Induce NETs
Fungi and the protein kinase C agonist PMA activate a similar
pathway to make NETs. Both induce MAPK signaling (Hakkim
et al., 2011), the activation of NOX2, and the production of
ROS (Fuchs et al., 2007). PMA is also a strong mitogen, a
chemical with the ability to trigger cell division. We tested if
other mitogens also lead to NET release. Concanavalin
A (ConA) and phytohaemagglutinin, two plant lectins commonly
used to induce proliferation of lymphocytes, both induced
NETs, distinguishable by their morphology and the colocaliza-
tion of nuclear and granular markers (Figures 1A and 1B).
Importantly, NET induction with mitogens was also dependent
on ROS production, since neutrophils isolated from chronic
granulomatous disease (CGD) patients, who have deficiencies
in NOX2, or those treated with diphenyleneiodonium, a
NOX2 chemical inhibitor, did not undergo NETosis (Figures
1A and 1B).
NETosis Is Accompanied by Induction of Cell Division
Markers
Neutrophils are terminally differentiated cells that have with-
drawn from the cell cycle and lost their capacity to divide.
Indeed, mature neutrophils downregulate most of the genes
involved in cell-cycle regulation (Klausen et al., 2004), a finding
we confirmed by genome-wide expression analysis of peripheral
blood neutrophils from healthy donors (Table S1). Despite this,
mitogenic stimulation of neutrophils leads to nuclear envelope
breakdown as it does in the case of mitosis in dividing cells.
Transmission electron microscopy comparing mitosis in the
myeloid cell line PLB-985, and NETosis in neutrophils, revealed
that the vesiculation of the nuclear envelope is common to
both processes (Figure 1C; Fuchs et al., 2007). We were struck
by this similarity and postulated that common cellular pathways
are employed during NETosis and mitosis.
We first examined cell-cycle markers in neutrophils induced to
make NETs. The nuclear antigen Ki-67 is expressed in all cycling
cells, irrespective of the stage of the cell cycle they are in, while it
is absent in non-cycling, quiescent, or senescent cells. Resting
neutrophils were negative for Ki-67 but, surprisingly, cells stimu-
lated to undergo NETosis transiently reactivated expression of
this cell division marker, visualized by immunofluorescence (Fig-
ures 2A and 2B).450 Developmental Cell 43, 449–462, November 20, 2017We examined a series of other cell-cycle markers, in the order
in which they are induced in dividing cells. Neutrophils are typi-
cally considered to be in the G0 stage, like other terminally differ-
entiated and quiescent cells (Figure S1). Cells in G0 can resume
cycling after mitogenic stimulation; this is associated with phos-
phorylation of pRb by CDK4/6 (Malumbres and Barbacid, 2009).
Notably, neutrophils stimulated to make NETs also exhibited
robust phosphorylation of pRb, indicating that activation of G1
kinases was occurring (Figure 2C). Importantly, pRb phosphory-
lation was not only triggered by PMA and ConA, but also by
infection with C. albicans hyphae (Figure 2C). Stimuli that acti-
vate neutrophils but do not induce NETs, such as bacterial pep-
tide analog N-formylmethionyl-leucyl-phenylalanine (fMLP), did
not lead to pRb phosphorylation.
Despite activation of G1 kinases, we did not detect incorpora-
tion of the thymidine analog 5-ethynyl-20-deoxyuridine (EdU)
(Figure 2D), indicating that DNA synthesis, the hallmark of S
phase, did not occur. As a control for EdU incorporation we
used continuously cycling HEK293 cells (Figure 2D) as well as
T lymphocytes, which can be induced to proliferate by treatment
with PMA, analogously to our stimulation of neutrophils. T cells
stimulated with PMA/ionomycin successfully incorporated
EdU, but this required a longer period of stimulation than the
3 hr it took neutrophils to make NETs (Figure S1B), highlighting
an important difference in the temporal dynamic between
NETosis and cell-cycle re-entry. Similarly, we observed no in-
duction of the S-phase transcriptional program in neutrophils
making NETs. In cycling cells, phosphorylation of pRb leads to
the derepression of E2F transcription factors and expression of
S-phase genes, but these were not induced in NETosis as
measured by qPCR analysis (Figure S1C) and whole-genome
microarray analysis (data not shown).
Our initial observation of nuclear envelope breakdown during
NETosis (Figure 1C) argued that mitotic pathways are also acti-
vated. Inmitosis (Mphase), nuclear envelopedisintegration is trig-
geredbyphosphorylationof lamins, intermediate filamentproteins
that form a sheet underneath the envelope called the nuclear
lamina (Heald and McKeon, 1990). Phosphorylation of the lamina
disrupts the structural rigidity of the nucleus, allowing the nuclear
envelope to disintegrate. We tested if NET formation is also asso-
ciatedwithphosphorylationof lamins.Remarkably, treatmentwith
the NET-inducing stimuli PMA, ConA, orC. albicans hyphae all led
to robust phosphorylation of lamin A/C (Figure 2C). This was
confirmed by immunofluorescence (Figures S1D and S1E).
Furthermore,NETosiswas accompaniedby induction of a second
mitotic marker: phosphorylation of histone H3 at serine 10
(H3S10). Neither lamin nor H3S10 phosphorylation were induced
by the control stimulus fMLP (Figure 2C), which, as mentioned
above, does not induce NETs.
Induction of NETs Leads to Centrosome Separation
To test whether NET formation involves induction of other mitotic
markers, we visualized microtubule dynamics by immuno-
fluorescence microscopy. During mitosis, microtubule-based
structures called centrosomes, which were duplicated in the
preceding S phase, separate and migrate to opposing poles
of the cell where they nucleate formation of the mitotic
spindle (Mardin and Schiebel, 2012). In unstimulated neutrophils,
immunostaining with an antibody directed against both a- and
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Figure 1. Mitogens Induce NETs
(A) Human peripheral blood neutrophils isolated from a healthy donor or CGD patient (n = 2) with a genetic deficiency in NOX2, stimulated with PMA (50 nM) or
ConA (50 mg/mL) for 5 hr. Both stimuli lead to colocalization of chromatin (red), DNA (blue), and the granule protein neutrophil elastase (green). Representative
image from three independent experiments. Nonstim, nonstimulated. Top row, merge; bottom row, DNA. Scale bars, 5 mm.
(B) Quantification of NET induction with mitogens and C. albicans, and inhibition with the NOX2 inhibitor diphenyliodonium (DPI, 5 mM). Representative result of
three independent repeats, means ± SD.
(C) Electron micrograph comparing nuclear envelope breakdown in mitosis and NETosis. Left: PLB-985 cells were synchronized in G2 and then released into
mitosis. In G2 the nuclear envelope is intact but disintegrates in the prophase of mitosis, concurrently with appearance of condensed chromosomes (darker
staining territories in the nucleus). In anaphase, chromosomes have separated and, eventually the nuclear envelope begins to reform. Right: nonstimulated
neutrophils have a lobulated nucleus, but this lobulation is lost as they prepare to release NETs. Approximately 2 hr after PMA stimulation, the nuclear envelope
starts to disintegrate, allowing nuclear material to mix with the contents of the granules and the cytoplasm before being released into the extracellular space. The
bottom row shows magnified details from corresponding top panels. Arrows indicate vesiculation of the nuclear envelope. Neutrophil images are representative
from at least five different embeddings. Scale bars, 5 mm (upper panels; overview) and 1 mm (lower panels; detailed views).
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b-tubulin demonstrated a ‘‘skeletal’’ or scaffold-like staining
pattern with several filaments extending from a central microtu-
bule-organizing center (Figures 2E and S1F). After 30min of PMA
stimulation these extended filaments were lost and rearranged
into single or double dot-like structures. Strikingly, 60 min
post-stimulation, these dot-like structures had duplicated and
migrated away from each other. The structures were most fully
separated from each other at 90 min post-stimulation and were
no longer present by 120 min, which coincided with breakdown
of the nuclear envelope. Immunofluorescence detection of the
centrosome marker g-tubulin confirmed that these structures
were bona fide centrosomes (Figures 2F and 2G). Treatment
with the control stimulus fMLP did not induce microtubule rear-
rangement (Figure S1G). Centrosome separation, together with
phosphorylation of lamins and histone H3S10, demonstrate
that markers of a mitotic program are present just before neutro-
phils die and release NETs.
Neutrophils Activate Cell-Cycle Signaling In Vivo
Induction of cell-cycle markers in neutrophils was surprising
since they are terminally differentiated cells. To verify that this
also occurs in vivo, we induced NETs by inoculating mice with
C. albicans via the orotracheal route. We then co-stained lung
sections with antibodies against neutrophil markers (calgranulin
A or Ly6G) and the cell division marker Ki-67. Interestingly, we
identified many Ki-67-positive neutrophils in the infected lungs
(Figures 3A and S2A).
We also examined human histological sections from patients
with brain fungal abscesses, identified by periodic acid-Schiff
staining (Figure S2B). We observed NETs in these sections by
detecting neutrophil elastase co-localizing with DNA (Fig-
ure S2C). Next, we co-stained sections with Ki-67 and the
neutrophil marker calgranulin, and indeed were able to observe
Ki-67-positive neutrophil infiltrates (Figure 3B). We confirmed
this finding using immunohistochemical methods with a second
Ki-67 antibody (Figure S2D), as well as immunofluorescent-
based detection of a second neutrophil marker (CD66b; Fig-
ure S2E). Neutrophils were only Ki-67 positive when they had
intact nuclei (NET precursors), as was the case with Ki-67 detec-
tion in purified neutrophils (Figure 2B). Remarkably, we could
also detect duplicated centrosomes in these cells (Figure 3C),
demonstrating the induction of mitotic pathways in neutrophils
in vivo and confirming our results with isolated human cells.Figure 2. NET Formation Is Associated with Induction of Cell-Cycle M
(A) Nonstimulated (nonstim, top panel) and PMA-treated human neutrophils staine
experiments. Scale bars, 5 mm.
(B) Quantification of nuclear Ki-67 staining during PMA time course stimulation. Th
SYTOX-positive cells (black). The graph shows means ± SEM from combined da
(C) Western blot of G1/S and M phase markers in lysates prepared from human
control stimulus that does not induce NETs (fMLP). ‘‘P-’’ indicates phosphoryl
Molecular weights are indicated in kDa.
(D) Immunofluorescence analysis of EdU incorporation in control HEK cells (left)
nucleotide analog EdU for 1 hr before PMA stimulation and were then fixed at in
control for 1 hr before fixing.
(E) Immunofluorescence detection of microtubules with an antibody against a- an
with PMA.
(F) Nonstimulated and PMA-treated (1 hr) human neutrophils stained for g-tubu
independent experiments, with cells from different donors. Scale bars 5 mm.
(G) Quantification of separated centrosomes from (F). Graph shows means ± SETheCell-Cycle Inhibitor p21cip RegulatesNETFormation
Human neutrophils are refractory to transfection and gene edit-
ing because of their short lifespans. As an initial approach to
determine whether NETosis is dependent on the cell cycle, we
used cell-penetrating peptides. In dividing cells, one class of
negative cell-cycle regulators is a family of small proteins termed
cip/kip (CDK interacting protein/Kinase inhibitory protein). The
prototype of this family is p21cip1 (p21), a protein that blocks
the cell cycle at several different points (Figure S1A) by inhibiting
cyclin-CDK complexes. We synthesized a peptide mimic corre-
sponding to the CDK inhibitory domain of p21 (Rousseau et al.,
1999), which was previously shown to inhibit proliferation by
interfering with the activity of CDKs. We coupled this peptide
to the cell-penetrating tat sequence (Goulvestre et al., 2005).
A scrambled peptide served as the control. Both peptides
penetrated neutrophils with similar efficiencies (Figure S3A),
and neither were toxic to the cells (Figure S3B). Transduction
of the p21 inhibitory peptide (p21inh) into human neutrophils
completely blocked NET formation, while transduction of the
control scrambled peptide (p21ctrl) had little effect (Figures 4A
and 4B). Interference with CDKs thus leads to inhibition of NET
release, indicating that these cell-cycle regulators are necessary
for NETosis. We also examined NET formation in p21 knockout
mice, whose cells have higher proliferative capacities due to
increased CDK activity and loss of cell-cycle control (Bedel-
baeva et al., 2010). As expected, peritoneal neutrophils from
p21 knockout mice made more NETs than wild-type (WT) cells
(Figure 4C), consistent with p21 being a regulator of both cell-cy-
cle and NET formation. ROS production, however, was similar in
both strains (Figure 4D).
Neutrophils Express CDK4/6
The early stages of NET formation display various cell-cycle
markers and can be blocked by the CDK binding domain of
the p21 cell-cycle inhibitor. CDKs and their regulatory subunits,
the cyclins, are the major drivers of the mammalian cell cycle
(Figure S1A). The CDKs are a large group of kinases, many of
which have functions unrelated to the cell cycle (Lim and Kaldis,
2013). Of the canonical cell-cycle regulatory kinases, the close
homologs CDKs 4 and 6 regulate the transition from G0 to G1
phase and are considered to be largely redundant (Malumbres
and Barbacid, 2009). CDK2 drives progression through S phase,
while CDK1 is essential for mitosis, although much functionalarkers
d for Ki-67 (red) and elastase (green). Representative image from four different
e percentage of Ki67-positive cells (gray) is plotted alongwith the percentage of
ta of four healthy donors.
neutrophils simulated with NET inducers (PMA, ConA, and C. albicans) and a
ation. Representative blot from three or more repeats with different donors.
and human neutrophils making NETs (right). Neutrophils were incubated with
dicated times. HEK cells (nonstimulated) were incubated with EdU or vehicle
d b-tubulin (red), in a time course experiment of human neutrophils stimulated
lin (red) and DNA (blue). (E and F) Representative images from three different
M from combined data of four donors. See also Figure S1.
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Figure 3. Neutrophils Activate Cell-Cycle Signaling In Vivo
(A and B) Immunostaining of mouse lung infected with C. albicans (A) or human brain fungal abscess (B) showing neutrophils labeled with calgranulin (red)
expressing Ki-67 (green) in the nucleus. Representative image from six mice or four different human specimens.
(C) Neutrophils (red/calgranulin) in human brain fungal abscess, showing duplicated and separated centrosomes (green). (A–C) Blue, DNA. Scale bars, 10 mm. See
also Figure S2.overlap has been reported (Figure S1A; Malumbres and Barba-
cid, 2009). We examined protein expression of the cell-cycle
CDKs in human neutrophils and were able to detect CDK4/6
(Figure 5A). CDK4 was present at the protein level, as well as
induced at the transcriptional level, after NET induction (Fig-
ure S4A), while CDK6 was only present at the protein level (Fig-
ure 5A). Neutrophils did not express CDK2 or CDK1 (Figures 5A454 Developmental Cell 43, 449–462, November 20, 2017and S4A), in agreement with previous reports (Leitch et al., 2012;
Klausen et al., 2004).
CDK4/6 are implicated in phosphorylation of pRb (Meyerson
and Harlow, 1994) and in centrosome separation (Hussain
et al., 2013) both of which occur during NET formation (Figures
2C and 2F). Furthermore, CDK4/6 activity can be induced via
MAPK signaling and is a central link between extracellular
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Figure 4. p21 Regulates NETs
(A) Human neutrophils were incubated with a peptide corresponding to the CDK inhibitory domain of the p21 protein (p21inh), or a scrambled control peptide
(p21ctrl), at a concentration of 20 mM before activation of NETs with PMA. The graph shows means ± SEM of NET formation after 4 hr. n = 3 donors. **p < 0.01,
unpaired Student’s t test.
(B) Representative immunofluorescence images of PMA-stimulated cells pre-incubated with p21 peptide or scrambled control, from three independent repeats.
DNA is shown in blue and chromatin in red. Scale bars, 10 mm.
(C) NET formation in WT and p21/ mouse peritoneal neutrophils after 5 hr of PMA stimulation. Bars show means ± SEM, n = 4 mice. ***p < 0.001, unpaired
Student’s t test.
(D) Oxidative burst in WT and p21/mouse peritoneal neutrophils in response to PMA. Bars showmeans of maximum luminescence intensity, ± SEM. n = 4; ns,
non-significant, unpaired Student’s t test. See also Figure S3.growth signals and induction of proliferation (Malumbres and
Barbacid, 2009). CDK6 localizes throughout the cytoplasm in
unstimulated neutrophils and transiently accumulates in the
nucleus of PMA-stimulated cells (Figure 5B). We could not deter-
mine the localization of CDK4. Neutrophils express the CDK4/6
regulatory co-factor cyclin D2 and low levels of cyclin D3
(Figure 5C).
CDK4/6 Controls NET Formation
To test if these G1 kinases are involved in NET formation, we
incubated human neutrophils with a CDK4/6 pharmacological in-
hibitor (abemaciclib/LY2835219), which efficiently blocked NETs
in a dose-dependent manner (Figures 5D, S4D, and S4E), but didnot inhibit the oxidative burst (Figure 5F), phagocytosis (Fig-
ure 5G), or degranulation (Figure S4F). This was confirmed with
a secondCdk4/6 inhibitor (palbociclib, Figure 5E). Both inhibitors
blocked ConA-induced NETs at lower concentrations than those
required for PMA, consistent with ConA being aweaker stimulus.
CDK4/6 inhibition blocked translocation of elastase to the nu-
cleus (Figure S4G), a requirement for NET release (Papayanno-
poulos et al., 2010).
CDK4/6 double knockout mice die at late stages of embryonic
development due to severe anemia (Malumbres et al., 2004). The
kinases have, however, been knocked out individually. Cdk6
knockout mice are viable and have only mild hematopoietic dis-
turbances (Malumbres et al., 2004; Hu et al., 2009). We used aDevelopmental Cell 43, 449–462, November 20, 2017 455
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Cdk6/mouse strain in which expression of the gene was inter-
rupted by insertion of a floxed transcriptional stop cassette in the
first exon (Hu et al., 2009). We purified neutrophils from the
peritoneum of Cdk6/ and WT mice (Figure S5A) and obtained
similar yields and purities (Figure S5B). Like human neutrophils,
mouse neutrophils expressedCdk4 aswell as Cdk6 (Figure S5A).
Despite this redundancy, Cdk6-deficient neutrophils were
impaired in NET production in response to both PMA and
C. albicans hyphae (Figures 5H and S5C). We obtained similar
results with bone marrow-purified neutrophils (Figure S5D).
The oxidative burst was unaffected in the knockout animals
(Figure 5I), similar to the result with the CDK4/6 inhibitor. There
was no difference in peritoneal neutrophil maturity between the
two genotypes, as revealed by expression level of the surface
marker Ly6G (Figure S5E) and nuclear morphology (Figure S5F).
Likewise, we observed no difference in cytokine production
(Figure 5J), indicating that Cdk6 deficiency specifically affects
NET production, rather than generally modulating inflammatory
pathways.
Cdk6 Is Required for Antifungal Defense In Vivo
To test the effect of Cdk6 and NET deficiency in infections, we
used the murine C. albicans sepsis model, which closely reflects
the human disease (Spellberg et al., 2005). In this model,
C. albicans colonizes the kidneys leading to renal failure (Spell-
berg et al., 2005). The host anti-Candida response is mediated
primarily by neutrophils (Fulurija et al., 1996), making this a
good model for investigating the effect of Cdk6 and NET defi-
ciency on immunity. Mice were intravenously injected with live
C. albicans and monitored over the course of the infection.
Cdk6/ animals lost weight more rapidly than WT animals (Fig-
ure 6A) and also succumbed to the diseasemore rapidly thanWT
animals (Figure 6B). Nox2-deficient animals, which are similarly
impaired in NET production, also showed reduced survival in
response to C. albicans challenge (Figure 6B).
We next infectedmice with a sublethal dose ofC. albicans and
compared fungal loads in the kidneys 5 days post-infection. We
found a strikingly elevated C. albicans fungal load in knockout
animals (Figure 6C). This effect was not due to differences in
peripheral blood counts of neutrophils (Figure S6A) or other
immune cells (Figure S5C). Cdk6 was previously implicated in
regulating cytokine production (Handschick et al., 2014), butFigure 5. Cdk4/6 Control NET Formation
For a Figure360 author presentation of Figure 5, see https://doi.org/10.1016/j.de
(A) Expression of CDKs in human neutrophils (neutro) and control T cells by wes
(B) Left: image showing subcellular localization of CDK6 in naive and PMA-stimul
5 mm. Right: Quantification of enrichment of CDK6 in neutrophil nuclei, n = 3 don
(C) Expression of cyclin D in human neutrophils (neutro) and control PLB-985
independent experiments with different donors.
(D and E) NET inhibition with the Cdk4/6 inhibitor abemaciclib (LY2835219) (D) and
data from four donors. Graph shows means and SEM.
(F) Oxidative burst in human neutrophils treated with Cdk4/6 inhibitor or vehicle.
(G) Phagocytosis of C. albicans by human neutrophils pretreated with vehicle (D
(H) NET formation in WT and Cdk6/ mouse peritoneal neutrophils after 5 hr
****p < 0.0001, ***p < 0.001.
(I) Oxidative burst measured by luminol assay in WT or Cdk6/ mouse periton
significant.
(J) Mip1a production in WT and Cdk6/ mouse neutrophils (n = 3 per group),
Student’s t test. See also Figures S4 and S5.we found equivalent, or even elevated numbers of neutrophils
infiltrating the kidneys of Cdk6/ animals on day 5 post-infec-
tion (Figure S6B), indicating that migratory capacity was unaf-
fected. The higher rates of neutrophil accumulation in knockout
mice was likely a reflection of higher fungal burdens in these an-
imals. Furthermore, bone marrow-derived macrophages from
WT and Cdk6 null mice produced pro- and anti-inflammatory
mediators at similar rates (Figure S6D).
Consistent with previous descriptions of sublethal C. albicans
infections (Fisher et al., 2011), histological analysis of infected
kidneys demonstrated that, 5 days post-infection, the fungus
produced hyphal filaments, which are associated with tissue
destruction, and that these hyphae were collecting in excretory
lesions in the papillae of the renal pelvis (Figure 6D). Immunoflu-
orescence analysis revealed that hyphal masses were more
abundant in knockout animals: 90% of Cdk6/ mice had
detectable hyphae in the renal papillae, compared with 25% of
WT mice.
Cdk6 is broadly expressed in hematopoietic and some
non-hematopoietic mouse tissues (Tigan et al., 2015), so its
contribution to proper immune defenses could derive from
non-myeloid cell activity. To investigate if Cdk6 is required in
neutrophils, we restored expression of the kinase in knockout
animals by breeding Cdk6/ mice with animals expressing
Cre recombinase (Cre) under the control of a lysozyme M pro-
moter (LysM-Cre). This driver leads to expression of Cre in cells
of the myeloid lineage, including neutrophils, monocytes, and
macrophages. Expression of Cre in neutrophils led to excision
of the floxed STOP cassette and restored Cdk6 to similar levels
as in WT mice (Figure S6C). Importantly, genetic rescue of Cdk6
in myeloid cells of knockout mice restored the ability of these
mice to mount proper immune responses against C. albicans
(Figure 6C), demonstrating a role for Cdk6 in antimicrobial
defense.
DISCUSSION
Neutrophils are terminally differentiated cells that have stopped
proliferating. Indeed, an analysis of cell-cycle proteins demon-
strated a downregulation of cyclins and CDKs as neutrophils
differentiate from hematopoietic precursors into mature cells
(Klausen et al., 2004). Here we show that, despite thisvcel.2017.10.013#mmc3.
tern blot analysis. Molecular weights indicated in kDa.
ated human neutrophils. DNA is shown in blue and CDK6 in green. Scale bars,
ors, bars show means and SEM. **p < 0.01, unpaired Student’s t test.
cells (PLB) by western blot. (A–C) Representative blots or image from three
palbociclib (PD-0332991) after 4 hr of PMA or ConA stimulation (E). Combined
Representative data from three independent repeats. Bars = mean and SD.
MSO, black), abemaciclib (red), and cytochalasin D (blue), n = 3 donors.
of stimulation with PMA or heat-killed C. albicans hyphae. n = 4 per group.
eal neutrophils stimulated with 100 nM PMA. n = 4 mice per group. ns, not
in response to LPS (200 ng/mL). (F–J) Graph shows means ± SEM, unpaired
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downregulation, neutrophils can re-activate some aspects of
cell-cycle signaling, most notably CDK4/6, upon mitogenic
stimulation. We show that NETosis is accompanied by upregula-
tion of Ki-67, phosphorylation of pRb, lamin A/C, and histone
H3S10, as well as duplication of centrosomes and nuclear enve-
lope breakdown. Neutrophil activation does not result in DNA
synthesis, condensation of chromosomes or cytokinesis, indi-
cating that cell-cycle re-entry is not occurring.
In dividing cells, the cell cycle is tightly controlled and rapidly
aborted in response to abnormalities, stress, or disruption of
the sequential order of events. Activation of these checkpoints
often results in cell death (Malumbres and Barbacid, 2009). It is
interesting to speculate that NETotic cell death also results
from triggering of one of these checkpoints. For instance, at-
tempted DNA replication without concomitant production of
histones arrests the cell cycle in G2 (Gunesdogan et al.,
2014). Furthermore, NET formation also requires production
of ROS (Fuchs et al., 2007), which can damage DNA and acti-
vate the DNA damage checkpoint in both dividing cells (Ma-
lumbres and Barbacid, 2009) and in neutrophils (Harbort
et al., 2015). At this point, it is unclear if CDK4/6 promote
NETs via cell-cycle signaling or completely unrelated path-
ways; therefore the involvement of checkpoints also remains
speculative.
ROS can also be mitogenic by activating growth factor recep-
tors (Verbon et al., 2012), but, in NETosis, NOX2-derived ROS do
not appear to be upstream of cell-cycle signaling, as phosphor-
ylation of pRb and lamin A/C proceeds unchanged in neutrophils
fromCGDpatients. CDK4/6 thus function in a parallel pathway to
ROS production; these kinases are necessary but not sufficient
for NET formation.
NET formation was inhibited by transduction of a peptide
mimic derived from the CDK binding domain of p21, providing
an indication that a CDK is involved in the process. p21 is an
endogenous cell-cycle inhibitor that blocks CDK activity, just
like the peptide mimic employed here. Cells from p21 null mice
have higher proliferative capacities (Balomenos et al., 2000)
and neutrophils from these mice also exhibited elevated rates
of NET formation. p21 knockout mice have been reported to
have stronger inflammatory reactions (Martin et al., 2016) and,
interestingly, p21 knockout mice also spontaneously develop
SLE (Balomenos et al., 2000), a chronic autoimmune disease
that has been associated with excessive NET release (Kaplan
and Radic, 2012) and accumulation of antibodies against DNA
and histones.
Mitogenic signaling in quiescent cells can lead to cell-cycle
restart by activating CDK4/6 (Tigan et al., 2015). Consistent
with this idea, we show that CDK4/6 are activated upon mito-
genic stimulation of neutrophils, and that these kinases regulate
NET formation. Our observation that CDK4/6 are the only cell-cy-
cle CDKs expressed in human neutrophils potentially explains
the unusual mix of cell-cycle markers induced during NET forma-
tion, since these kinases are active in both phosphorylating pRb(C) C. albicans CFU expressed per gram of kidney tissue in WT, Cdk6/, and co
CFU. Lines indicate median. **p < 0.01; *p < 0.05 Mann-Whitney U test. ns, not
(D) C. albicans (red) and neutrophils (Ly6G, green) in papillae of renal pelvis (v
Representative image of nine analyzed kidneys per genotype. Scale bar, 200 mmin G1 phase, and inducing centrosome separation in M phase
(Hussain et al., 2013). It remains unclear, however, if CDK4/6
control NETs via cell-cycle substrates or via targets that are
unrelated to cell-cycle control. pRb phosphorylation and centro-
some separation could thus simply be markers of CDK4/6
activation, rather than being integral to the mechanism of NET
release.
CDK6 is predominantly expressed in blood cells where it
plays a role in T cell development and lymphomagenesis
(Hu et al., 2009, 2011). It regulates cell-cycle re-entry in certain
subsets of hematopoietic precursors (Laurenti et al., 2015;
Scheicher et al., 2015), but, despite this, levels of peripheral
blood leukocytes, including neutrophils, are normal in Cdk6
knockout mice (Figure S5), probably due to compensation
from Cdk4. Alternative roles for Cdk6 as a transcriptional regu-
lator have also been uncovered (Handschick et al., 2014). It is
unlikely that Cdk6 regulates NETs via transcriptional regulation,
since NET formation is independent of de novo gene expres-
sion (Sollberger et al., 2016). Furthermore, the fact that
ROS and cytokine production, as well as surface marker
expression, are unperturbed in Cdk6/ neutrophils, argues
against a defect in differentiation or a general deficiency in in-
flammatory signaling.
We identify a role for Cdk6 in innate immune defense. Mice
lacking this kinase are highly susceptible to infection with the
fungal pathogen C. albicans. In acute systemic candidiasis, the
immune response is predominantly mediated by neutrophils
and not by T cell responses, since mice lacking T cells do not
show any increase in susceptibility to disease (Cutler, 1976).
CDK6 was shown to regulate cytokine production in HeLa cells
(Handschick et al., 2014), but we failed to detect a defect in
neutrophil recruitment to infected organs. Macrophages, the
major producers of cytokines during infections, produced
normal levels of these inflammatory mediators despite lacking
CDK6. Elevated kidney fungal loads are thus likely a reflection
of a defect in neutrophil function, specifically one in NET forma-
tion, although the use of the LysM-Cre driver in the rescue exper-
iment means we cannot rule out other impairments in myeloid
cells. Cdk6 was shown to regulate macrophage adhesion in
response to lipopolysaccharide LPS, and knockout mice are
protected against LPS-induced sepsis (Hennessy et al., 2011).
This finding is in line with a role for Cdk6 in NET formation, since
NETs are also implicated in the pathology of sepsis (Camicia
et al., 2014).
NETs are important for immune defense, but are also dysre-
gulated in many autoimmune diseases. Intriguingly, a genetic
polymorphism in CDK6 has been associated with rheumatoid
arthritis (Raychaudhuri et al., 2008). CDK6 expression levels
are also elevated in various types of cancer, and inhibition of
this kinase appears to be a promising new antitumor therapy
(Tigan et al., 2015). It is of note that malignancies such as chronic
myelogenous leukemia are associated with high levels of NET-
induced thrombosis (Demers et al., 2012). The contribution ofnditional rescue Cdk6/; LysM-Cre+ mice, 5 days post-infection with 13 105
significant.
isualized by DNA stain/blue) of WT and Cdk6/ mice, day 5 post-infection.
. See also Figure S6.
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CDK6 to cancer may thus be 2-fold: cell-cycle dysregulation
contributing to tumorigenesis as well as increased NET forma-
tion by myeloid cell precursors leading to thrombosis, the sec-
ond most common cause of death in cancer patients (Rickles
et al., 1992). Use of CDK4/6 inhibitors in cancer therapy may
consequently lower rates of thrombosis, but also dampen im-
mune responses in patients.
Interestingly, other instances exist where cell-cycle signaling
in postmitotic cells has been linked to disease (Herrup and
Yang, 2007). In the brain, neurons can inappropriately re-activate
the cell cycle, which leads to cell death just as it does in neutro-
phils. Cell death resulting from neuron cell-cycle re-entry has
been linked to several neurodegenerative diseases, including
Alzheimer’s disease and amyotrophic lateral sclerosis (Busser
et al., 1998; Herrup and Yang, 2007). Dysregulation of cell-cycle
proteins in postmitotic neurons and neutrophils can thus be
viewed as a unifying disease principle in neurodegenerative
and inflammatory disorders.
In summary, NET formation, an antimicrobial form of cell
death, is controlled by the activation of the cell-cycle kinases
CDK4/6. During infection, lymphocytes activate the cell cycle
to rapidly increase their numbers and thus fulfill their memory
or cytotoxic functions.We show that, in neutrophils, similar path-
ways are used for regulating the NETotic cell death program,
with essential consequences for immunopathology and defense
against pathogens. These findings open up avenues for thera-
peutic interventions in NET-related diseases.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Ki67 Abcam ab16667, RRID: AB_302459
a/b Tubulin Cell Signaling Cat. No. 2148, RRID: AB_2288042
pericentrin Abcam ab4448, RRID: AB_304461
Lamin A/C phospho-ser392 (immunofluorescence) Biorbyt orb99257
Cdk6 (for human detections) Santa Cruz Cat. No. 177 (C-21) RRID: AB_631225
Cdk6 (for mouse detections) Abcam ab54576, RRID: AB_940952
Elastase LsBio B24-244
g tubulin Thermo MA1-19421, RRID: AB_1075282
anti-chromatin (reacts with a complex of Histone 2A,
Histone 2B and DNA)
Monestier lab Losman et al., 1992
Cdk4 (for human detections) Abcam EPR4513, RRID: AB_10861376
Cdk4 (for mouse detections) Genetex GTX102993, RRID: AB_1949951
CCND1 Santa Cruz sc-753, RRID: AB_2070433
CCND2 Santa Cruz sc-593, RRID: AB_2070794
CCND3 Cell Signaling 2936, RRID: AB_10698739
CCNE1 Cell Signaling HE12, RRID: AB_2071200
CCNE2 Abnova 10197, RRID: AB_1671803
CCNB1 Cell Signaling 4138, RRID: AB_2072132
CCNA2 Cell Signaling BF683, RRID: AB_2071958
CDK2 Cell Signaling 78B2, RRID: AB_10695594
CDK7 Thermo PA5-34791, RRID: AB_2552143
phospho-Lamin A/C S22 Cell Signaling 2026, RRID: AB_2136155
Lamin A/C Cell Signaling 2032, RRID: AB_2136278
phospho histone H3 S10 Cell Signaling 9701, RRID: AB_331535
phospho pRb S780 Cell Signaling 9307, RRID: AB_330015
GAPDH Cell Signaling 2118, RRID: AB_561053
Bacterial and Virus Strains
Candida albicans Urban lab, Umea University SC5314
Biological Samples
Human blood This study N/A
Chemicals, Peptides, and Recombinant Proteins
Abemaciclib Selleck LY2835219
Ribociclib Selleck PD-0332991
SYTO Green Thermo Fisher S7575
SYTOX Orange Thermo Fisher S11368
P21inh peptide
Ac-YGRKKRRQRRRRERWNFDFVTETPLEGDFAW-NH2
Peptide 2.0 Inc N/A
P21 ctrl peptide
Ac-YGRKKRRQRRRLWARDENDEVFRWFTPEFGT-NH2
Peptide 2.0 inc N/A
Deposited Data
Microarray data GEO repository GSE103755
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REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental Models: Organisms/Strains
Cdk6 knockout mouse Hinds lab, Tufts University B6.129S4-Cdk6tm1/J
P21 knockout kouse Jackson labs B6.129S6(Cg)-Cdkn1atm1Led/J
LysM-Cre transgenic mouse Jackson labs B6.129P2-Lyz2tm1(cre)Ifo/J
Oligonucleotides
b2-microglobulin F
5’-CTCCGTGGCCTTAGCTGTG-3’
Sigma N/A
b2-microglobulin R
5’-TTTGGAGTACGCTGGATAGCCT-3’
Sigma N/A
Software and Algorithms
ImageJ imagej.net N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents should be directed to and will be fulfilled by the Lead Contact, Arturo Zychlinsky
(zychlinsky@mpiib-berlin.mpg.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Samples
Our study was conducted in accordance with the Helsinki Declaration. Blood donations from healthy donors (male and female, ages
23-53) and CGD patient (male, age 23) were collected after obtaining informed consent. Information on sample size can be found in
the figure legends. Histopathological samples were collected anonymously from diagnostic biopsies and autopsies, therefore sex
and age reporting is not possible. Both blood and pathology sample collection was approved by the ethical committee of Charite´
University Hospital, Berlin, Germany.
Mice
Mouse breeding and experiments were approved by the Berlin state authority Landesamt f€ur Gesundheit und Soziales. Animals were
bred locally at the Max Planck Institute for Infection Biology. They were housed in approved specific pathogen free (SPF) conditions,
maintained on a 12-hour light/dark cycle and fed ad libitum. Cdk6/ mice (B6.129S4-Cdk6tm1/J) were generated by a knock-in
approach (Hu et al., 2009) and obtained from the Hinds laboratory. They were bred homozygous. p21/mice, generated in the Leder
lab (B6.129S6(Cg)-Cdkn1atm1Led/J) were obtained from Jackson laboratory and were bred homozygous. For conditional rescue of
Cdk6 in myeloid cells, cdk6/ mice were crossed with LysM- Cre mice (B6.129P2-Lyz2tm1(cre)Ifo/J), obtained from Jackson labora-
tory. Experiments were carried out with male and female sex- and age-matched 8-12 week old mice that were confirmed to be
infection free and had not been exposed to any previous procedures. For estimation of group size we used the software nQuery.
Experimenters were not blinded to animal genotype. For group sizes and statistical tests please see figure legends.
Mouse Infections
C. albicans strain SC5314 was grown as an overnight culture in YPDmedium at 30Cwith shaking. For lung infections, 106 cfu in PBS
were delivered via the oral-tracheal route into 8 week old female wild-type C57B6 mice (n=6). Mice were sacrificed and lungs were
removed 18 hours later and fixed in 2% PFA.
For disseminated candidiasis, two different doses were used: for survival experiments, animals were injected intravenously (i.v.)
with 5x105 cfu and monitored daily. For kidney fungal load, renal histology and immune cell infiltration assays, 8 week old female
mice were injected i.v. with 1x105 cfu. After 5 days, animals were sacrificed and kidneys were removed. One kidney was homoge-
nized in a Precellys Evolution bead homogenizer (Bertin technologies) for plating and cfu determination and the other was processed
for FACS analysis. For group sizes and statistical tests please see figure legends.
Cell Line
PLB-985 cells (female; RRID:CVCL_2162) were kindly donated by Dr. Mary Dinauer. They were cultured according to standard
protocols in RPMI medium with 10% FCS, glutamine and antibiotics. Cells were used exclusively for controls or as a reference.
They were not checked for contamination with mycoplasma or with other cell lines. Synchronization in G2 phase was achieved by
incubating cells in presence of 10 mM RO3306 for 14 hours, followed by washing and reseeding in normal medium.e2 Developmental Cell 43, 449–462.e1–e5, November 20, 2017
METHOD DETAILS
Purification of Human Peripheral Blood Neutrophils
Venous blood was collected into EDTA tubes (S-Monovette, Sarstedt), layered on Histopaque 1119 (Sigma-Aldrich) and centrifuged
for 20min at 8003 g. The plasma and upper layers consistingmainly of lymphocytes andmonocytes were discarded (or collected for
T cell purification). The neutrophil-rich layer was collected, leaving the red blood cells on the bottom of the tube. Neutrophils were
washed in PBS, and further fractionated on a discontinuous Percoll (Pharmacia) gradient consisting of layers with densities of
1105 g/ml (85%), 1100 g/ml (80%), 1093 g/ml (75%), 1087 g/ml (70%), and 1081 g/ml (65%). After centrifugation for 20 min at
800 3 g, the interface between the 80% and 85% Percoll layers was collected and washed with PBS. Neutrophil purity was deter-
mined to be > 95% by FACS.
NET Induction and Quantification
Human NETs were induced in culture medium consisting of RPMI supplemented with HEPES (10 mM) and 0.05% human serum
albumin (HSA, Grifols), with 50 nM PMA (Sigma), 50 mg/ml ConA (Sigma), 50 mg/ml PHA (Sigma) or liveC. albicans (previously opson-
ized in human serum) at a multiplicity of infection (MOI) of 5. Cells were stimulated with mitogens for 4 hours and with C. albicans for
2 hours.
NETs were enumerated using a SYTO/SYTOX staining technique. The cell impermeable SYTOX orange dye (1 mM, Thermofisher)
was used to detect NETs. SYTO green, a cell-permeable DNA dye (250 nM, Thermofisher), was used to determine the total number of
cells. Imageswere taken on a Leica DM IRBE invertedmicroscope. Percentage of NET release was calculated by dividing the number
of SYTOX positive cells by the number of SYTO positive cells. For studies with chemical inhibitors, cells were plated directly into cul-
ture medium containing the inhibitors. Preincubation with Abemaciclib (LY2835219, Selleck) and Palbociclib (Selleck) was for 30 min
at the indicated concentrations. Stock solutions of inhibitors were made by dissolving in DMSO and stored for one week at room
temperature after which they were discarded.
Immunofluorescence
Neutrophils were fixed on uncoated glass coverslips with 2% paraformaldehyde (PFA), permeabilized for 5 minutes with 0.5%
Triton X-100, and then blocked at room temperature for 30 minutes in 1% bovine serum albumin, 5% normal donkey serum,
and 3% cold-water fish gelatin (Sigma-Aldrich). To promote attachment of unstimulated cells, neutrophils were first plated for
5minutes in RPMIwithout human serum albumin, after which culturemediumwas added (RPMI with 0.05%HSA). Primary antibodies
used were: anti-Ki67 (Abcam SP6), anti-a/b Tubulin (Cell Signaling Technology [CST]), anti-pericentrin (Abcam), anti- Lamin A/C
phospho-ser392 (Biorbyt), anti-Cdk6 (Santa Cruz, C-21), anti-elastase (EMD), anti-g tubulin (Thermo) and anti-chromatin (reacts
with a complex of Histone 2A, Histone 2B and DNA, (Losman et al., 1992)). Samples were stained with primary antibodies for 1h
at 37C in blocking buffer, followed by secondary antibodies conjugated to Alexa Fluor 488 or 568 (Invitrogen) together with Hoechst
33342. Coverslips were mounted in Mowiol and images were taken with a Leica SP8 confocal microscope.
Transmission Electron Microscopy
Cells were fixed with 2.5% glutaraldehyde, postfixed with 1% osmiumtetroxide, contrasted with uranylacetate and tannic acid, de-
hydrated and embedded in Polybed (Polysciences). Specimens were then cut at 60 nm and contrasted with lead citrate. Analysis was
carried out on a Leo 906E transmission electron microscope (Oberkochen).
Western Blotting
Protein immunoblotting was performed as previously described (Harbort et al., 2015), with lysates prepared directly in hot SDS
loading dye. Primary antibodies used were as follows: anti-CDK6 (Santa Cruz, c-21 [for detecting human protein]), anti-Cdk6
(Abcam ab54576, [for detecting mouse protein]), anti-CDK4 (Abcam EPR4513 [for detecting human protein]), anti-Cdk4
(Genetex GTX102993 [for detecting mouse protein]), anti-CCND1, CCND2, CCND3 (Santa Cruz), anti-CCNE1 (CST HE12),
anti-CCNE2 (Abnova 10197), anti-CCNA2 (CST BF683), anti-CCNB1 (CST 4138), anti-CDK1 (Abcam, clone A17), anti-CDK2
(CST 78B2), anti-CDK7 (Thermo Fisher PA5-34791), anti-phospho-Lamin A/C (S22 [CST]), anti-Lamin A/C (CST), anti-phospho
histone H3 (S10 [CST]), anti-Histone H3 (CST), anti-phospho pRb (S780 [CST D59B7]), anti-pRb (CST) anti-Ki67 (Abcam SP6) and
anti-GAPDH (CST).
Microarray Analysis
RNA from 8 healthy donors was isolated using RNeasy mini kit (Qiagen) and labeled with the Fluorescent Linear Amplification Kit
(Agilent Technologies) according to manufacturer’s instructions before hybridization to whole-genome 4344k human expression
arrays (Agilent). Data analysis was performed using the limma R package. Expression values were background-corrected followed
by quantile normalization between samples.Developmental Cell 43, 449–462.e1–e5, November 20, 2017 e3
Quantitative Real-Time PCR
RNA was isolated with RNeasy mini kit (Qiagen). cDNA was made using High-capacity RNA-to-cDNA kit (Applied Biosystems)
according to manufacturer’s protocol. qPCR was performed on StepOnePlus Real-Time PCR System with 2x Fast SYBR Green
master mix (Applied Biosystems). The housekeeping gene
b2-microglobulin (F 5’-CTCCGTGGCCTTAGCTGTG-3’ and
R 5’-TTTGGAGTACGCTGGATAGCCT-3’) was used as an internal control for relative standard curves. All other cDNAs were
amplified with Quantitect primer (Qiagen). Data were analyzed using StepOne software.
Peptide Inhibition Experiments
Tat conjugated peptides were synthesized by Peptide 2.0 Inc (Chantilly, VA, USA). p21inh, corresponding to amino acids 46–65 of
the p21 protein: Ac-YGRKKRRQRRRRERWNFDFVTETPLEGDFAW-NH2; p21ctrl: Ac-YGRKKRRQRRRLWARDENDEVFRWFT
PEFGT-NH2. Neutrophils were incubated with 20 mM of peptides for 1 hour in Hank’s Balanced Salt Solution (HBSS) without
magnesium or calcium ions, with orbital rotation. Subsequently, the cells were diluted 1:20 in culture medium, plated and stimulated
with PMA.
EdU Incorporation Assay
DNA synthesis wasmonitored using the Click-iT EdU Alexa Fluor 488 Imaging Kit (Thermo Fisher) as per manufacturer’s instructions.
Neutrophils, T cells or HEK cells were incubated with EdU for 20min before stimulation (in the case of neutrophils and T cells). Control
human T cells were purified from peripheral blood mononuclear cell (PBMC) fractions. After separation on Histopaque 1119 (Sigma-
Aldrich), PBMCs were stimulated with PHA, incubated for 5 days and then restimulated with 20 ng/ml PMA and 200 ng/ml ionomycin
to induce proliferation in the presence of EdU.
Mouse NETs
Mouse peritoneal neutrophils were elicited with casein (Sigma) and purified on a Percoll gradient as previously published (Swamydas
et al., 2015). Mouse bone marrow neutrophils were purified as previously described (Sollberger et al., 2016). Cells were stimulated in
RPMI supplemented with 1% DNase/ mouse serum and 100 ng/ml G-CSF (Peprotech) with either PMA (100 nM) or heat killed
C. albicans hyphae (Sollberger et al., 2016) for the indicated times.
Histology
Human biopsy and autopsy tissue was fixed in formalin and embedded in paraffin. Four micrometer thick paraffin sections were
stained using routine Periodic acid–Schiff (PAS) staining or with antibodies against Ki-67 (MiB1, Dako) by using the iView-Ventana
diaminobenzidine (DAB) Detection Kit (Ventana) with biotinylated secondary antibodies and DAB visualization of the peroxidase
reaction product with a Benchmark XT immunostainer (Ventana).
Mouse lungs and kidneys were fixed in 2% PFA, embedded in paraffin and cut to 5 mm sections.
Immunofluorescence experiments were carried out with anti-Ki67 (Abcam SP6), anti-pericentrin (Abcam), anti-Calgranulin
A (S100A8) (produced in-house) and anti- C. albicans (Acris BP1006) primary antibodies, followed by Alexa secondary antibodies
(Invitrogen).
Microscopy was performed with a Leica SP8 confocal microscope.
Mouse Peripheral Blood Counts
Cell populations in whole blood were identified and quantified by flow cytometry with the following antibodies: anti- CD115
(AF598, eBioscience), anti-Gr-1 (RB6-8C5, Biolegend), anti-CD3 (17A2, BD Bioscience), anti-CD4 (RM4-5, BD Bioscience), CD8a
(53-6.7, BD Bioscience), anti-B220 (RA3-6B2, Biolegend). Antibodies were added directly to 100 mL of heparinized whole blood at
a 1:200 dilution and incubated at room temperature for 30 minutes. Stained cells were fixed and erythrocytes were lysed simulta-
neously with 1-step Fix/Lyse solution (Affymetrix eBioscience). AccuCheck Counting beads (Invitrogen) were added to obtain total
cell counts. Samples were acquired on a BD LSRFortessa using DIVA software and analyzed by Flowjo (Treestar) software.
ROS Assay
Neutrophils were seeded in 96-well plates at a concentration of 1x105 cells per well in 200 ml medium supplemented with 50 mM
luminol and 1.2 units/ml horseradish peroxidase, both from Sigma. After 30 minute incubation at 37C, cells were stimulated with
100 nM PMA and luminescence was measured over time in a VICTOR Light luminescence counter (Perkin Elmer) and expressed
as Relative Light Units (RLU).
Phagocytosis Assay
Green fluorescent protein (GFP)-expressing C. albicans strain sc5314 (kind gift of Brendan Cormack) was opsonized with 10%
human serum for 20 minutes and incubated with purified human neutrophils. For inhibitor experiments, neutrophils were pretreated
with compounds for 30 minutes. Phagocytocis was allowed to proceed for 30 minutes at 37C with rotation in RPMI supplemented
with 0.1% human serum albumin, after which cells were fixed with 2% PFA. Neutrophils were labelled with an anti-CD15 antibody
coupled with allophycocyanin (APC). Percentage phagocytosis was determined by FACS analysis of GFP and APC positive cells.e4 Developmental Cell 43, 449–462.e1–e5, November 20, 2017
Degranulation Assay
Human neutrophils were stimulated with opsonized zymosan (10 mg/ml) or medium for 2 hours to stimulate degranulation of elastase.
Zymosan (Sigma) was opsonized with 10% pooled human serum from 6 donors for 30 minutes at 37C. Elastase release in super-
natants was quantified using the human elastase ELISA kit (Hycult).
Purification of Kidney Immune Infiltrate
Neutrophils in infected kidneys were analyzed as outlined in (Swamydas et al., 2015). Briefly, kidneys were finely sliced with a scalpel
and digested for 30min in the presence of 0.2125mg/ml Liberase TL (Roche) and 0.1mg/ml DNase I (Roche). After digestion, kidneys
were strained through a 70 mm sieve, red cells were lysed with ACK lysis buffer (Lonza) and the pellet was resuspended in 40%
Percoll. This was loaded over 70% Percoll and centrifuged at 872x g for 30 min. Cells were collected from the interface and analyzed
by FACS.
QUANTIFICATION AND STATISTICAL ANALYSIS
GraphPad Prismwas used to generate graphs and perform all statistical tests. For NET assays, immunofluorescence quantifications,
ROS production, phagocytosis and cytokine secretion, graphs show means +/- standard error of the mean and unpaired t test was
used for statistical comparisons. Mann-Whitney U test was used for comparing cfu enumeration and neutrophil counts. Survival data
were analyzed by the Kaplan-Meier method with Mantel-Cox log-rank testing. Details of statistical analyses for quantifications are in
corresponding figure legends, including significance levels, exact n values and what n represents for each experiment.
DATA AND SOFTWARE AVAILABILITY
The values for microarray expression analysis have been deposited in GEO repository as GEO: GSE103755.Developmental Cell 43, 449–462.e1–e5, November 20, 2017 e5
